These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 7588997)
1. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma. Simmons RB; Newton GR; Doctor VM Eur J Drug Metab Pharmacokinet; 1995; 20(1):73-7. PubMed ID: 7588997 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of potentiation of antithrombin III and heparin cofactor II inhibition by sulfated xylans. Carson L; Doctor VM Thromb Res; 1990 May; 58(4):367-81. PubMed ID: 1972302 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides. Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of potentiation of antithrombin III [AT-III] inhibition by sulfated xylans. Campbell A; Nesheim ME; Doctor VM Thromb Res; 1987 Aug; 47(3):341-52. PubMed ID: 2442830 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate. Sié P; Fernandez F; Caranobe C; Gabaig AM; Boneu B Thromb Res; 1984 Jul; 35(2):231-6. PubMed ID: 6206589 [No Abstract] [Full Text] [Related]
6. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III. Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716 [TBL] [Abstract][Full Text] [Related]
7. Fluorescence and circular dichroism studies during the interactions of sulfated polysaccharides with antithrombin III. Tanyi A; Benjamin V; Sadberry AJ; Doctor VM Thromb Res; 1995 Mar; 77(6):505-13. PubMed ID: 7542805 [TBL] [Abstract][Full Text] [Related]
8. Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration. Sié P; Lansen J; Lacheretz F; Verschuere B; Boneu B Thromb Haemost; 1986 Dec; 56(3):302-7. PubMed ID: 2436331 [TBL] [Abstract][Full Text] [Related]
9. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54). Scully MF; Kakkar VV Thromb Res; 1984 Oct; 36(2):187-94. PubMed ID: 6209821 [TBL] [Abstract][Full Text] [Related]
10. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides. Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917 [TBL] [Abstract][Full Text] [Related]
11. Selective activation of heparin cofactor II by a sulfated polysaccharide isolated from the leaves of Artemisia princeps. Hayakawa Y; Hayashi T; Hayashi T; Niiya K; Sakuragawa N Blood Coagul Fibrinolysis; 1995 Oct; 6(7):643-9. PubMed ID: 8562835 [TBL] [Abstract][Full Text] [Related]
12. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin. Church FC; Meade JB; Treanor RE; Whinna HC J Biol Chem; 1989 Feb; 264(6):3618-23. PubMed ID: 2914965 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of thrombin inhibition by heparin cofactor II in the presence of dermatan sulphates, native or oversulphated, and a heparin-like dextran derivative. Maaroufi RM; Jozefowicz M; Tapon-Bretaudière J; Jozefonvicz J; Fischer AM Biomaterials; 1997 Feb; 18(4):359-66. PubMed ID: 9068899 [TBL] [Abstract][Full Text] [Related]
15. Binding of heparin or dermatan sulfate to thrombin is essential for the sulfated polysaccharide-accelerated inhibition of thrombin by heparin cofactor II. Yamagishi R; Koide T; Sakuragawa N FEBS Lett; 1987 Dec; 225(1-2):109-12. PubMed ID: 3691797 [TBL] [Abstract][Full Text] [Related]
16. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma. Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790 [TBL] [Abstract][Full Text] [Related]
17. Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin. Liaw PC; Becker DL; Stafford AR; Fredenburgh JC; Weitz JI J Biol Chem; 2001 Jun; 276(24):20959-65. PubMed ID: 11294849 [TBL] [Abstract][Full Text] [Related]
18. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II. Scully MF; Ellis V; Seno N; Kakkar VV Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851 [TBL] [Abstract][Full Text] [Related]
19. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans. Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876 [TBL] [Abstract][Full Text] [Related]
20. Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex. Preissner KT; Sié P Thromb Haemost; 1988 Dec; 60(3):399-406. PubMed ID: 2976993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]